Phase I pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS-214662, a farnesyltransferase inhibitor, in patients with advanced solid tumors (Q45265094)
Jump to navigation
Jump to search
scientific article published on 14 February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS-214662, a farnesyltransferase inhibitor, in patients with advanced solid tumors |
scientific article published on 14 February 2005 |
Statements
1 reference
Phase I pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS-214662, a farnesyltransferase inhibitor, in patients with advanced solid tumors (English)
1 reference
1 reference
Josep Maria Del Campo
1 reference
Fredy Rojo
1 reference
Irene Marimón
1 reference
Maurizio Voi
1 reference
Joan Albanell
1 reference
Marta Guix
1 reference
Federico Vázquez
1 reference
Joan Carulla
1 reference
Michael Cooper
1 reference
Jordi Andreu
1 reference
Anne Van Vreckem
1 reference
Joaquim Bellmunt
1 reference
James A Manning
1 reference
Carmen Garrido
1 reference
Mónica García
1 reference
Sonia Valverde
1 reference
José Baselga
1 reference
14 February 2005
1 reference
1 reference
Identifiers
1 reference